• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PET/CT 在肝转移瘤管理中的价值,第 1 部分。

Value of PET/CT in the management of liver metastases, part 1.

机构信息

Boston University School of Medicine, Boston, MA 02118, USA.

出版信息

AJR Am J Roentgenol. 2011 Aug;197(2):W256-9. doi: 10.2214/AJR.10.6331.

DOI:10.2214/AJR.10.6331
PMID:21785050
Abstract

OBJECTIVE

Metastasis is the most common (95%) of liver lesions. Early diagnosis and staging are the keys to treatment planning and prognosis. There is a consistent benefit to the use of PET/CT for detecting hepatic, local, and distant metastases from a variety of primary malignancies, which can contribute to staging and ultimately helps to establish the best course of treatment and to determine prognosis.

CONCLUSION

For colorectal cancer, FDG PET and FDG PET/CT are particularly effective for identification of additional hepatic and extrahepatic metastases, frequently upstaging the tumor stage and affecting management. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for liver metastases.

摘要

目的

转移是最常见的(95%)肝脏病变。早期诊断和分期是治疗计划和预后的关键。对于各种原发性恶性肿瘤的肝、局部和远处转移的检测,PET/CT 的使用具有一致的益处,这有助于分期,最终有助于确定最佳治疗方案并确定预后。

结论

对于结直肠癌,FDG PET 和 FDG PET/CT 对于识别额外的肝内和肝外转移特别有效,经常对肿瘤分期进行升级并影响治疗管理。此外,PET/CT 在局部消融和系统治疗评估以及肝转移的监测中非常有用。

相似文献

1
Value of PET/CT in the management of liver metastases, part 1.PET/CT 在肝转移瘤管理中的价值,第 1 部分。
AJR Am J Roentgenol. 2011 Aug;197(2):W256-9. doi: 10.2214/AJR.10.6331.
2
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.18F-氟脱氧葡萄糖正电子发射断层扫描在肝细胞癌术前分期检测肝外转移中的作用
Oncology. 2007;72 Suppl 1:104-10. doi: 10.1159/000111715. Epub 2007 Dec 13.
3
Controversies in the management of colorectal liver metastases: role of PET and PET/CT.结直肠癌肝转移管理中的争议:PET及PET/CT的作用
Dig Surg. 2008;25(6):413-20. doi: 10.1159/000184732. Epub 2009 Feb 12.
4
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.PET/CT 在原发性肝胆肿瘤治疗中的应用价值,第 2 部分。
AJR Am J Roentgenol. 2011 Aug;197(2):W260-5. doi: 10.2214/AJR.11.6995.
5
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.氟-18-脱氧葡萄糖正电子发射断层扫描在结直肠癌肝转移管理中的影响
Cancer. 2005 Dec 15;104(12):2658-70. doi: 10.1002/cncr.21569.
6
PET/CT: will it change the way that we use CT in cancer imaging?正电子发射断层显像/计算机断层扫描(PET/CT):它会改变我们在癌症成像中使用计算机断层扫描(CT)的方式吗?
Cancer Imaging. 2006 Oct 31;6(Spec No A):S52-62. doi: 10.1102/1470-7330.2006.9012.
7
Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在结直肠癌肝转移诊断与治疗中的作用
Expert Rev Anticancer Ther. 2004 Aug;4(4):607-13. doi: 10.1586/14737140.4.4.607.
8
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.通过[18F]FDG PET评估不可切除的结直肠癌肝转移灶的90Y玻璃微球治疗反应:与CT或MRI的比较
Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):815-20. doi: 10.1007/s00259-002-0787-4. Epub 2002 Mar 29.
9
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.F-18氟脱氧葡萄糖正电子发射断层扫描在乳腺癌患者随访中诊断肿瘤复发和转移:与传统成像的比较
Invest Radiol. 2003 May;38(5):250-6. doi: 10.1097/01.RLI.0000063983.86229.f2.
10
Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.结直肠癌肝转移灶激光诱导热疗后局部控制情况的评估:FDG-PET在临床怀疑疾病进展患者中的作用
Acta Radiol. 2007 Oct;48(8):821-30. doi: 10.1080/02841850701545771.

引用本文的文献

1
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study.阿替利珠单抗联合贝伐单抗加或不加根治性转化治疗经动脉化疗栓塞不适合的中期肝细胞癌患者实现完全缓解和无药状态:一项多中心概念验证研究
Liver Cancer. 2023 Feb 7;12(4):321-338. doi: 10.1159/000529574. eCollection 2023 Sep.
2
Diagnostic performance of whole-body [F]FDG PET/MR in cancer M staging: A systematic review and meta-analysis.全身 [F]FDG PET/MR 在癌症 M 分期中的诊断性能:系统评价和荟萃分析。
Eur Radiol. 2024 Jan;34(1):673-685. doi: 10.1007/s00330-023-10009-3. Epub 2023 Aug 3.
3
Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma.用于肝细胞癌成像的正电子发射断层显像(PET)放射性药物的最新进展
Cancers (Basel). 2023 Mar 25;15(7):1975. doi: 10.3390/cancers15071975.
4
Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review.人工智能在肝细胞癌诊断中的应用:一项系统综述。
J Clin Med. 2022 Oct 28;11(21):6368. doi: 10.3390/jcm11216368.
5
The Role of F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors.F-FLT PET/CT在评估原发性和转移性肝肿瘤患者经动脉放射性栓塞和化疗栓塞早期反应中的作用
Mol Imaging Radionucl Ther. 2022 Oct 19;31(3):207-215. doi: 10.4274/mirt.galenos.2022.85579.
6
Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma.阿替利珠单抗联合贝伐珠单抗序贯根治性转化(ABC转化)用于不可切除、不适合经动脉化疗栓塞术的中期肝细胞癌患者
Liver Cancer. 2022 Jul 27;11(5):399-406. doi: 10.1159/000526163. eCollection 2022 Sep.
7
Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer.肝脏正电子发射断层扫描:在代谢、血流动力学和癌症中的应用
Metabolites. 2022 Apr 2;12(4):321. doi: 10.3390/metabo12040321.
8
Evaluation of Hybrid PET/MRI for Gross Tumor Volume (GTV) Delineation in Colorectal Cancer Liver Metastases Radiotherapy.用于结直肠癌肝转移放疗中大体肿瘤体积(GTV)勾画的PET/MRI融合技术评估
Cancer Manag Res. 2021 Jul 6;13:5383-5389. doi: 10.2147/CMAR.S316969. eCollection 2021.
9
Usefulness of respiratory-gated PET acquisition during delayed F-FDG PET/CT scanning for patients with liver metastases.呼吸门控PET采集在延迟F-FDG PET/CT扫描中对肝转移患者的应用价值
Asia Ocean J Nucl Med Biol. 2021 Spring;9(2):12-149. doi: 10.22038/AOJNMB.2021.53427.1365.
10
Comparison of MRI and 18F-FDG PET/CT in the Liver Metastases of Gastrointestinal and Pancreaticobiliary Tumors.MRI与18F-FDG PET/CT在胃肠道和胰胆管肿瘤肝转移中的比较
Sisli Etfal Hastan Tip Bul. 2021 Mar 17;55(1):12-17. doi: 10.14744/SEMB.2020.80270. eCollection 2021.